Clinical outcomes in OPAT patients treated with ceftriaxone 4 g and ceftazidime 6 g extended interval dosing regimens
Loading...
Authors
Contact
Check for full-text access
Issue Date
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Background: Mitral valve regurgitation (MR) is associated with worse outcomes in patients undergoing percutaneous coronary intervention (PCI). We sought to evaluate outcomes of Impella-supported high-risk PCI (HRPCI) patients according to MR severity.
Description
Citation
Publisher
License
Journal
JAC-Antimicrobial Resistance
Volume
6
Issue
3
